Loading...
XTAE
NISA
Market cap27mUSD
May 12, Last price  
1,068.00ILS
1D
0.00%
1Q
-13.59%
Jan 2017
-72.52%
Name

Nissan Medical Industries Ltd

Chart & Performance

D1W1MN
P/E
1,227.07
P/S
14.61
EPS
0.87
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
1.87%
Revenues
664m
-9.52%
466,789,000512,208,000529,957,000509,478,000584,389,000658,386,000605,462,000721,481,000668,372,000684,647,000733,914,000664,079,000
Net income
8m
+39.95%
46,702,000603,00037,132,00017,909,00012,709,00025,102,00015,709,00056,846,00036,012,000-36,049,0005,649,0007,906,000
CFO
27m
-74.62%
72,612,00077,113,000120,183,00044,178,00052,352,00085,837,00055,764,000122,569,00017,978,00011,674,000105,715,00026,833,000
Dividend
Mar 01, 202244 ILS/sh

Profile

Nissan Medical Industries Ltd, through its subsidiary, engages in the manufacturing and marketing of spunlace non-woven fabrics in the United States, Canada, Europe, and Israel. The company's products are used in reusable and consumable consumer products, medical products, automotive, infrastructure, hygienic, and other industries. It sells its products through its sales agents. Nissan Medical Industries Ltd was incorporated in 1984 and is based in Tel Aviv-Yafo, Israel.
URL
IPO date
Jan 01, 1993
Employees
386
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
664,079
-9.52%
733,914
7.20%
684,647
2.44%
Cost of revenue
609,299
649,221
666,037
Unusual Expense (Income)
NOPBT
54,780
84,693
18,610
NOPBT Margin
8.25%
11.54%
2.72%
Operating Taxes
1,352
8,781
269
Tax Rate
2.47%
10.37%
1.45%
NOPAT
53,428
75,912
18,341
Net income
7,906
39.95%
5,649
-115.67%
(36,049)
-200.10%
Dividends
(6,813)
(3,997)
Dividend yield
5.12%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
150,153
120,832
119,409
Long-term debt
63,940
91,792
144,075
Deferred revenue
Other long-term liabilities
5,378
52,602
5,081
Net debt
183,285
173,177
208,024
Cash flow
Cash from operating activities
26,833
105,715
11,674
CAPEX
(6,090)
(9,819)
(9,693)
Cash from investing activities
(3,869)
(9,925)
(9,678)
Cash from financing activities
(32,370)
(90,714)
(25,781)
FCF
46,465
83,946
(21,129)
Balance
Cash
17,293
25,052
19,508
Long term investments
13,515
14,395
35,952
Excess cash
2,751
21,228
Stockholders' equity
337,792
338,328
323,547
Invested Capital
562,656
602,895
564,912
ROIC
9.17%
13.00%
3.30%
ROCE
9.01%
13.98%
2.93%
EV
Common stock shares outstanding
9,084
9,084
Price
13.09
21.20%
10.80
25.68%
8.59
-60.78%
Market cap
98,107
25.68%
78,059
-60.78%
EV
406,900
420,188
EBITDA
84,421
115,835
47,260
EV/EBITDA
3.51
8.89
Interest
13,339
21,266
10,016
Interest/NOPBT
24.35%
25.11%
53.82%